Adaptive Biotechnologies CorpEigentümerstruktur
| Preis (2026-07-30) | 52W Hoch | 52W Tief |
| 24.18 USD | 24,34 USD | 10,02 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 22,286 USD | 3 | 4 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 160.044.392 | 8,99 | 2,94 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Adaptive Biotechnologies Corp
Mitarbeiter 624
Handelsplatz NASDAQ
Ticker Symbol ADPT
IPO Datum 2019-06-27
Adresse 1165 Eastlake Avenue East, Seattle, WA, United States, 98109
Webseite https://www.adaptivebiotech.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Chad M. Robins M.B.A. | Co-Founder, CEO & Chairman |
| 2 | Ms. Julie Rubinstein | President & COO |
| 3 | Mr. Kyle Piskel | VP, CFO & Principal Accounting Officer |
| 4 | Ms. Susan Bobulsky | Chief Commercial Officer of MRD |
| 5 | Mr. Christopher Carlson Ph.D. | Founder |
| 6 | Ms. Karina Calzadilla | Vice President of Investor Relations |
| 7 | Ms. Clarice McCauley | Head of Legal, Corporate Secretary, VP & Chief Compliance Officer |
| 8 | Mr. Francis T. Lo | Chief People Officer |
| 9 | Dr. Sharon Benzeno Ph.D. | Chief Commercial Officer of Immune Medicine |
| 10 | Ms. Mary Pat Lancelotta | Senior Vice President of MRD BioPharma |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Viking Global Investors LP | 0,00% | 0,00 Mio. USD |
| 2 | BlackRock Inc | 0,00% | 0,00 Mio. USD |
| 3 | Vanguard Group Inc | 0,00% | 0,00 Mio. USD |
| 4 | Vanguard Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 5 | Westfield Capital Management Company, L.P. | 0,00% | 0,00 Mio. USD |
| 6 | Vanguard Portfolio Management, LLC | 0,00% | 0,00 Mio. USD |
| 7 | Amvescap Plc. | 0,00% | 0,00 Mio. USD |
| 8 | Wellington Management Company LLP | 0,00% | 0,00 Mio. USD |
| 9 | Geode Capital Management, LLC | 0,00% | 0,00 Mio. USD |
| 10 | Lord, Abbett & Co LLC | 0,00% | 0,00 Mio. USD |
| 11 | The Goldman Sachs Group Inc | 0,00% | 0,00 Mio. USD |
| 12 | State Street Corp | 0,00% | 0,00 Mio. USD |
| 13 | Ameriprise Financial Inc | 0,00% | 0,00 Mio. USD |
| 14 | BNP Paribas Investment Partners SA | 0,00% | 0,00 Mio. USD |
| 15 | ARK Investment Management LLC | 0,00% | 0,00 Mio. USD |
| 16 | Fred Alger Management, LLC | 0,00% | 0,00 Mio. USD |
| 17 | Arrowstreet Capital Limited Partnership | 0,00% | 0,00 Mio. USD |
| 18 | D. E. Shaw & Co LP | 0,00% | 0,00 Mio. USD |
| 19 | Delaware Management Holdings Inc | 0,00% | 0,00 Mio. USD |
| 20 | Driehaus Capital Management LLC | 0,00% | 0,00 Mio. USD |